The largest database of trusted experimental protocols

Prl cmv renilla control plasmid

Manufactured by Promega

The PRL-CMV Renilla control plasmid is a laboratory reagent used to facilitate gene expression studies. It contains the Renilla luciferase gene under the control of the CMV promoter, which allows for the expression of the Renilla luciferase protein.

Automatically generated - may contain errors

2 protocols using prl cmv renilla control plasmid

1

Transcriptional Impact of Somatic Mutations

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine the effects of recurrent somatic mutations on transcription, wild-type and mutant regions 201bp in length and centered on each mutation were synthesized and cloned into the KpnI and NheI site of the pGL4.23[luc2/pmin] luciferase reporter construct (Promega). Lung adenocarcinoma (NCI-H1437), esophageal adenocarcinoma (KYSE-450) and bladder carcinoma (Ku-19-19) cells, growing in 96-well plates, were transfected in quadruplicate with 200ng of the pGL4.23 reporter construct and 40ng of the pRL-CMV Renilla control plasmid (Promega). Forty-eight hours post-transfection luciferase activity was measured using the Dual-Glo Luciferase Assay System (Promega). Statistically significant differences in the relative luciferase activities between wild-type and mutant regions were determined using a two-sided Student’s t-Test, assuming equal variance. Visually the variance appears equal between the tested data and there is no biologically reason they should be different.
+ Open protocol
+ Expand
2

Transcriptional Impact of Somatic Mutations

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine the effects of recurrent somatic mutations on transcription, wild-type and mutant regions 201bp in length and centered on each mutation were synthesized and cloned into the KpnI and NheI site of the pGL4.23[luc2/pmin] luciferase reporter construct (Promega). Lung adenocarcinoma (NCI-H1437), esophageal adenocarcinoma (KYSE-450) and bladder carcinoma (Ku-19-19) cells, growing in 96-well plates, were transfected in quadruplicate with 200ng of the pGL4.23 reporter construct and 40ng of the pRL-CMV Renilla control plasmid (Promega). Forty-eight hours post-transfection luciferase activity was measured using the Dual-Glo Luciferase Assay System (Promega). Statistically significant differences in the relative luciferase activities between wild-type and mutant regions were determined using a two-sided Student’s t-Test, assuming equal variance. Visually the variance appears equal between the tested data and there is no biologically reason they should be different.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!